Skip to main content
Fig. 1 | BMC Medical Genomics

Fig. 1

From: Pancancer analysis of the prognostic and immunological role of FANCD2: a potential target for carcinogenesis and survival

Fig. 1

Expression of the FANCD2 gene in pan-cancer. A The TIMER database was used to analyze the expression of the FANCD2 gene in different cancers or specific cancer sub-types. B The expression distribution of the FANCD2 gene in tumor and normal tissues from TCGA. C The CPTAC dataset was used to analyze the protein expression level of FANCD2 in normal and primary tissues of breast cancer, RCC, UCEC, LUSC, LIHC, and GBM. D The IHC images of FANCD2 in normal and tumor tissues extracted from the HPA. *P < 0.05, **P < 0.01, and ***P < 0.001

Back to article page